Get documents about "Research Supplementary Questions 2011 2
W
Document Sample
Application ID:
CIA Surname:
Supplementary Questions
CANCER COUNCIL APPLICATIONS FOR PROJECT GRANTS COMMENCING 2012
IMPORTANT NOTE TO APPLICANTS:
Multi-state grant applications have been removed from this process. These will now
be funded via a funding partnership between Cancer Australia and Cancer Council
Australia (see Cancer Australia website for details).
Applications to the Cancer Councils comprise of:
The NHMRC RGMS application, which is to be submitted to the NHMRC in
accordance with their guidelines, and
The Supplementary Questions document, which is to be submitted by your
institution's Research Admin Officer (RAO) as a PDF file to the Cancer Council
Grants Secretariat (CancerCouncilGrants@cancervic.org.au).
The same application ID must be used on both the NHMRC application and the
Supplementary Questions document. Please name your document [application
ID]_SuppQs_[CIA Surname] eg 191919_SuppQs_Smith
Closing Date: Tuesday 8 March 2011
Please insert application ID and CIA surname in the header
Please use Times New Roman 12 font for all responses
For Yes / No answers, please place an X to the left of the preferred option
1. Chief Investigator A – contact details (for correspondence)
Application ID
Name
Department
Institution
Address
Suburb State Postcode
Telephone No Email
2. Administering Institution
Please include name and department address of Research Admin Officer (RAO)
Name of RAO
Department
Institution
Address
Suburb State Postcode
Telephone No Email
3. Scientific Title of your project
[Click here and type]
1
Application ID:
CIA Surname:
4. Which Cancer Council are you applying to?
Please place an X to the left of the Cancer Council you are applying to.
Cancer Council ACT
Cancer Council New South Wales
Cancer Council Queensland
Cancer Council South Australia
Cancer Council Tasmania
Cancer Council Victoria
Cancer Council Western Australia
INVESTIGATORS
5. Please list all Chief Investigators and Associate Investigators who will be named
on the Cancer Council application, and the Institution they are located in.
(insert additional rows as required)
NOTE: For Cancer Council Queensland and Cancer Council Victoria applications, the list and
sequence of investigators must be the same on both the NHMRC and Cancer Council application
Chief Investigator Institution
(Title, First name & Surname)
Associate Investigator Institution
(Title, First name & Surname)
6. Is the list and/or sequence of Investigators on the Cancer Council application
the same as on the NHMRC application form?
NOTE: This question is not applicable for Cancer Council Queensland and Cancer Council Victoria
applicants.
Yes Go to Question 7
No a) Please briefly explain why the list of investigators has changed
b) If there are Chief Investigators named on this application that are not named on
the NHMRC application, please attach to the end of this document, one page of
Track Record information and list of publications for the last 5 years
[Click here and type]
2
Application ID:
CIA Surname:
RELEVANCE TO CANCER
7. Relevance to the causes, diagnosis, treatment or prevention of cancer
Please include information on the relevance to cancer in your response, including how you might
progress the results of your work and its translation into clinical practice. The application will be
considered insufficiently relevant if the relevance and significance to another disease is greater than
to cancer, or if the research is of such a fundamental nature that its likely short or medium term
impact on cancer control is low.
(½ page maximum)
[Click here and type]
8. Specific State criteria
Please address any specific criteria that the Cancer Council may have. These are available on their
respective web sites. See http://www.cancervic.org.au/grantprocess for links. (½ page maximum)
[Click here and type]
BUDGET AND SCOPE OF RESEARCH
9. Is your application also being considered for funding by the NHMRC?
Yes Go to next question
No Go to Question 11
10. Scope of Research
What modifications to your project will be required in order for it to fit with the level of funding being
offered by the Cancer Council? Please provide details about the aims that will be retained and the
aims that will be removed due to the reduced level of funding and/or reduced number of years.
Include a timeline showing which aims will be carried out in year 1, year 2, etc. Please also include
details about the changes to budget across these years. (1 page maximum)
[Click here and type]
11. Budget
Please summarise the budget you wish to be considered by the Cancer Council
Named Person Level Year 1 Year 2 Year 3
Equipment
Maintenance
3
Application ID:
CIA Surname:
Total
RESEARCH SUPPORT
12. Cancer Council Research Grants held by any of the Chief Investigators during
the period 2006-2010
Publications arising from
Application ID Cancer Council funding held
Chief Investigators, Project Title, Year(s) grant held
(if known) (referenced to Publications List
in application eg 14, 17, 23)
COMMON SCIENTIFIC OUTLINE
The Common Scientific Outlines in Question 13 are the result of collaborative effort between the NCI
in the US, the NCRI in the UK, and their partners. It is a classification system organised around seven
broad areas of scientific interest in cancer research, plus subgroups. Click on the following link to view
category descriptions in full http://www.cancerportfolio.org/cso.jsp
13. Which categories of research best describe your application? Please select all
that are applicable.
Biology
1.1 Normal functioning
1.2 Cancer initiation: Alterations in chromosomes
1.3 Cancer initiation: Oncogenes and tumour suppressor genes
1.4 Cancer progression and metastasis
1.5 Resources and infrastructure
1.6 Cancer related biology
Aetiology
2.1 Exogenous factors in the origin and cause of cancer
2.2 Endogenous factors in the origin and cause of cancer
2.3 Interactions of genes and/or genetic polymorphisms with exogenous and/or
endogenous factors
2.4 Resources and infrastructure related to aetiology
Prevention
3.1 Interventions to prevent cancer: Personal behaviours that affect cancer risk
3.2 Nutritional science in cancer prevention
4
Application ID:
CIA Surname:
3.3 Chemoprevention
3.4 Vaccines
3.5 Complementary and alternative prevention approaches
3.6 Resources and infrastructure related to prevention
Early Detection, Diagnosis, and Prognosis
4.1 Technology development and/or marker discovery
4.2 Technology and/or marker evaluation with respect to fundamental parameters of
method
4.3 Technology and/or marker testing in a clinical setting
4.4 Resources and infrastructure related to detection, diagnosis, or prognosis
Treatment
5.1 Localised therapies – Discovery and development
5.2 Localised therapies – Clinical
5.3 Systemic therapies – Discovery and development
5.4 Systemic therapies – Clinical applications
5.5 Combinations of localised and systemic therapies
5.6 Complementary and alternative treatment approaches
5.7 Resources and infrastructure related to treatment
Cancer Control, Survivorship, and Outcomes Research
6.1 Patient care and survivorship issues
6.2 Surveillance
6.3 Behaviour related to cancer control
6.4 Cost analyses and healthcare delivery
6.5 Education and communication
6.6 End-of-Life care
6.7 Ethics and confidentiality in cancer research
6.8 Complementary and alternative approaches for supportive care of patients and
survivors
6.9 Resources and infrastructure related to cancer control, survivorship, and outcomes
research
Scientific Model Systems
7.1 Development and characterisation of model systems
7.2 Application of model systems
7.3 Resources and infrastructure related to scientific model systems
5
Application ID:
CIA Surname:
6
